High-flow nasal oxygen reduces endotracheal intubation: a randomized clinical trial

BACKGROUND: The benefits of high-flow nasal cannula (HFNC) as primary intervention in patients with acute hypoxemic respiratory failure (AHRF) are still a matter in debate. Our objective was to compare HFNC therapy versus conventional oxygen therapy (COT) in the prevention of endotracheal intubation...

Descripción completa

Detalles Bibliográficos
Autores principales: Andino, Ricardo, Vega, Gema, Pacheco, Sandra Karina, Arevalillo, Nuria, Leal, Ana, Fernández, Laura, Rodriguez, María Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522841/
https://www.ncbi.nlm.nih.gov/pubmed/32976085
http://dx.doi.org/10.1177/1753466620956459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522841/
https://www.ncbi.nlm.nih.gov/pubmed/32976085
http://dx.doi.org/10.1177/1753466620956459

Ejemplares similares